5.7.2
Aplastic Anaemia
Malawi Standard Treatment Guidelines, 6th Edition, 2023. Chapter 5, Blood and Haematology.
Clinical Description
It is an abnormality in at least 2 blood cell lines with hypocellular bone marrow.
Causes
Primary causes: Inherited (e.g., Fanconi anaemia) or idiopathic (acquired and accounts about 67% of aplastic anaemia cases)
Secondary causes: Chemicals (e.g., benzene, toluene, glue sniffing), drugs (e.g., chemotherapeutic drugs, chloramphenicol, gold, penicillamine, phenytoin, carbamazepine, azathioprine), insecticides, ionizing radiation, infections (e.g., HIV, EBV, Viral hepatitis, TB, Parvovirus B19), paroxysmal nocturnal haemoglobinuria and pregnancy.
Signs and Symptoms
- Easy bruising, bleeding, blood blisters in the mouth
- Pallor
- Petechiae
- Purpura
- Bleeding
- Frequent or severe infections
Investigations
- FBC: Pancytopenia
- PBF: Reduced blood cells and absence of reticulocytes
- Bone marrow aspiration and trephine: hypocellular bone marrow
- Other investigations: to exclude secondary causes (e.g., HIV, TB screen, Hepatitis B and C serology)
- Refer to central hospital for further workup
Treatment
- Treatment is largely supportive
- Treat infections aggressively
- If anaemic and/or bleeding, transfuse whole blood and/or platelets
- If neutropenic and febrile: antibiotics
Complications and Referral Criteria
- Discuss all cases of suspected aplastic anaemia with a haematologist/specialist.
- Stabilise the patient, if necessary, with blood products before referral.
Check doses against the printed guideline and your clinical judgement before treating a patient. Spotted an error? Report it from the contact links below.
Need this without data?
The app holds every guideline on your device, with calculators, bookmarks and notes.